Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications for Cystectomy in Bladder Cancer
Conrad M. Tobert(University of Iowa), Kenneth G. Nepple(University of Iowa), Tracy M. Downs(University of Wisconsin–Madison), Douglas Robertson(University of Iowa), Nathan A. Brooks(Eli Lilly (United States)), Jill Hamilton‐Reeves(University of Minnesota), Chermaine Hung(University of Iowa), Lyse A. Norian(University of Alabama at Birmingham), Jeff M. Holzbeierlein(University of Kansas), Ruth Grossman(University of Iowa)
Cited by 90
Related Papers
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
|European Urology|2014|297
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190
Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study
|Journal of Clinical Oncology|2017|175
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
|Nature Reviews Urology|2021|154